Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active... – Nitrogen heterocycle
Patent
1993-09-30
1996-03-12
Webman, Edward J.
Drug, bio-affecting and body treating compositions
Solid synthetic organic polymer as designated organic active...
Nitrogen heterocycle
424 7804, 424 7805, 424441, 424449, 424456, 424 45, 424423, 514826, 514887, 514914, A61K 31785, A61K 906, A61K 912, A61K 920
Patent
active
054984106
ABSTRACT:
A method is provided for treating a hypersensitivity disease comprising parenterally administering to a human afflicted with such a disease an amount of an anionic polymer effective to counteract the symptoms of a disease selected from the group consisting of bronchial asthma, eosinophil-associated nasal inflammation and vernal conjunctivitis, by counteracting the effect of at least one cationic toxin released by the eosinophils of said human.
REFERENCES:
patent: 3074852 (1963-01-01), Mayron
patent: 3202557 (1965-08-01), Kaufman
patent: 3330729 (1967-07-01), Johnson
patent: 3608063 (1971-09-01), Banker
patent: 4021387 (1977-05-01), Goetzl et al.
patent: 4226848 (1980-10-01), Nagai et al.
patent: 4322402 (1982-03-01), Ishikawa et al.
patent: 4795436 (1989-01-01), Robinson
patent: 4816449 (1989-03-01), Hahn
patent: 4937232 (1990-06-01), Bell et al.
patent: 5000936 (1991-03-01), Chibret
patent: 5036056 (1991-07-01), Kludas
patent: 5250293 (1993-10-01), Gleich
patent: 5324510 (1994-06-01), Wegner et al.
G. J. Gleich, et al., "Physiochemical and Biological Properties of the Major Basic Protein From Guinea Pig Eosinophil Granules," Jounral of Experimental Medicine, 140(2), pp. 313-332 (1974).
T. Ahmed et al., "Preventing Bronchoconstriction in Exercise-Induced Asthma with Inhaled Heparin", The New England Journal of Medicine, 329, 90-95 (1993).
J. P. Arm et al., "The Pathobiology of Bronchial Asthma", Adv. Immunol., 51, 323-382 (1992).
G. H. Ayars et al., "Injurious Effect of the Eosinophil Peroxide-Hydrogen Peroxide-Halide System and Major Basic Protein on Human Nasal Epithelium In Vitro", Am. Rev. Resp. Dis., 140, 125-131 (1989).
L. G. Baird et al., "Effects of Polyanion Immunomodulators on the Immune System" in Anionic Polymeric Drugs; L. G. Donaruma et al., eds.; Wiley-Interscience, NY; pp. 185-210; 1980.
R. L. Barker et al., "Acidic Polyamino Acids Inhibit Human Eosinophil Granule Major Basic Protein Toxicity", J. Clin. Invest., 88, 798-805 (1991).
R. L. Barker et al., "Acidic Polyamino Acids Inhibit Human Eosinophil Granule Major Basic Protein Toxicity", FASEB J., 4, A1699, Abstr. 26 (Apr. 26, 1990).
D. W. Barnes, "Effects of Anionic Polymeric Drugs and Other Immunoactive Agents on Hepatic Microsomal Mixed-Function Oxidases" in Anionic Polymeric Drugs; L. G. Donaruma et al., eds,; Wiley-Interscience, NY; pp. 255-275; 1980.
R. Bascom et al., "Major basic protein and eosinophil-derived neurotoxin concentrations in nasal-lavage fluid after antigen challenge: Effect of systemic corticosteroids and relationship to eosinophil influx", J. Allergy Clin. Immunol., 84, 338-345 (1989).
S. M. Berge et al., "Pharmaceutical Salts", J. Pharm. Sci., 66, 1-19 (1977).
D. S. Breslow, "Biologically Active synthetic Anionic Polymers", Am. Chem. Soc. Symposium Series, 195, 1-9 (1982).
C. J. Corrigan et al., "T Cells and eosinophils in the pathogenesis of asthma", Immunology Today, 13, 501-507 (1992).
P. L. DeAngelis et al., "Specific recognition of sulfate esters by bindin, a sperm adhesion protein from sea urchins", Biochim. et Biophys. Acta, 1037, 100-105 (1990).
M. S. Dunnill, "The Pathology of Asthma, with Special Reference to changes in the Bronchial Mucosa", J. Clin. Path., 13, 27-33 (1960).
A. G. Ellis et al., "The Pathological Anatomy of Bronchial Asthma", J. Med. Sci., 136, 407-429 (1908).
W. Filley et al., "Identification by Immunofluorescence of Eosinophil Granule Major Basic Protein in Lung Tissues of Patients with Bronchial Asthma", Lancet, 2, 11-16 (1982).
E. Frigas et al., "Cytotoxic Effects of the Guinea Pig Eosinophil Major Basic Protein on Tracheal Epiothelium", Lab. Invest., 42, 35-43 (1980).
E. Frigas et al., "The eosinophil and the pathophysiology of asthma", J. Allergy clin. Immunol., 77, 527-537 (1986).
E. Frigas et al., "Elevated Levels of the Eosinophil Granule Major Basic Protein in the Sputum of Patients with Bronchial Asthma", Mayo Clinic, Proc., 56, 345-353 (1981).
A. D. Fryer et al., "Function of Pulmonary M.sub.2 Muscarinic Receptors in Antigen-challenged Guinea Pigs Is Restored by Heparin and Poly-L-Glutamate", J. Clin. Invest., 90, 2292-2298 (1992).
G. J. Gleich et al., "Identification of a Major Basic Protein in Guinea Pig Eosinophil Granules", J. Exp. Med., 137, 1459-1471 (1973).
G. J. Gleich, "Cytotoxic Properties of the Eosinophil Major Basic Protein", J. Immunol., 123, 2925-2927 (1979).
G. J. Gleich, "The Eosinophilic Leukocyte: Structure and Function" Adv. Immunol., 39, 177-253 (1986).
G. J. Gleich, "Current Understanding of Eosinophil Function", Hospital Practice, 137-160 (Mar. 15, 1988).
G. J. Gleich et al., "The eosinophil as a mediator of damage to respiratory epithelium: A model for bronchial hyperreactivity", J. Allergy Clin. Immunol., 81, 776-781 (1988).
G. J. Gleich, "The eosinophil and bronchial asthma: Current understanding", J. Allergy and Clin. Immunol., 85, 422-436 (1990).
N. J. Gross et al., "Anticholinergic Drugs" in Allergy, Principles and Practice, (3rd ed); E. Middleton, Jr. et al., eds; The C. V. Mosby Company: St. Louis, MO; pp. 782-808; 1988.
E. J. Goetzl et al., "Eosinophil Polymorphonuclear Leukocyte Function in Immediate Hypersensitivity", Arch. Pathol., 99, 1-4 (1975).
R. H. Gundel et al., "Repeated antigen inhalation results in a prolonged airway eosinophilia and airway hyperresponsiveness in primates", J. Appl. Physiol., 68, 779-786 (1990).
R. H. Gundel et al., "Human Eosinophil Major Basic Protein Induces Airway Contriction and Airway Hyperresponsiveness in Primates", J. Clin. Invest., 87, 1470-1473 (1991).
A. T. Hastie et al., "The Effect of Purified Human Eosinophil Major Basic Protein on Mammalian Ciliary Activity", Am. Rev. Resp. Dis., 135, 848-853 (1987).
E. M. Hodnett et al., "Anionic Polymers and Biological Activities. Effects of Some New Polycarboxylic Acids on the Ascitic Sarcoma 180 of Mice", J. Med. Chem., 21, 652-657 (1978).
B. R. Horn et al., "Total Eosinophil Counts in the Management of Bronchial Asthma", N. Engl. J. Med., 292, 1152-1155 (1975).
D. B. Jacoby et al., "Human Eosinophil Major Basis Protein is an Endogenous Allosteric Antagonist at the Inhibitory Muscarinic M2 Receptor", J. Clin. Invest., 91, 1314-1318 (1993).
D. A. Lane et al., "Non-Anticoagulant Uses of Heparin", The New England Journal of Medicine, 329, 129-130 (1993).
P. J. Mauser et al., "The Effect of Anti-IL-5 on Antigen-Induced Airway Hyperreactivity and Pulmonary Eosinophilia in Guinea Pigs", Am. Rev. Resp. Dis., 145, A859, 1992.
S. Motojima et al., "Toxicity of Eosinophil Cationic Proteins for Guinea Pig Tracheal Epithelium In Vitro", Am. Rev. Respir. Dis., 139, 801-805 (1989).
R. M. Ottenbrite, "Introduction to Polymers in Biology and Medicine" in Antionic Polymeric Drugs, L. G. Donaruma et al., eds,; Wiley-Interscience, NY; pp. 1-20; 1980.
R. M. Ottenbrite, "Structure and Biological Activities of Some Polyanionic Polymers" in Anionic Polymeric Drugs, L. G. Donaruma et al., eds.; Wiley-Interscience, NY; pp. 21-48; 1980.
N. R. Slifman et al., "Eosinophils: Biochemical and Cellular Aspects" in Allergy, Principles and Practice, (3rd ed); E. Middleton, Jr. et al., eds; The C. V. Mosby Company: St. Louis, MO; pp. 179-205; 1988.
S. D. Trocme et al., "Conjunctival Deposition of Eosinophil Granule Major Basic Protein in Vernal Keratoconjunctivitis and Contact Lens-Associated Giant Papillary Conjunctivitis", Am. J. Ophthamol., 108, 57-63 (1989).
I. J. Udell et al., "Eosinophil Granule Major Basic Protein and Charcot-Leyden Crystal Protein in Human Tears", Am. J. Ophthamol., 92, 824-828 (1981).
N. Wallen et al., "Glucocorticoids Inhibit Cytokine-Mediated Eosinophil Survival", J. Immunol., 147 3490-3595 (Nov. 15, 1991).
A. J. Wardlaw et al., "Eosinophils and Mast Cells in Bronchoalveolar Lavage in Subjects with Mild Asthma", Am. Rev. Resp. Dis., 137, 62-69 (1988).
T. L. Wasmoen et al., "Biochemical and Amino Acid Sequence Analysis of Human Eosinophil Granule Major Basic Protein", J. Biol. Chem., 263, 12559-12563 (1988).
C. D. Wegner et al., "Dynamic Respiratory Mechanics in Monkeys Measured by Forced Osillations", Respir. Physiol., 55, 47-61 (1984).
P. F.
LandOfFree
Method for the treatment of eosinophil-associated conditions wit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the treatment of eosinophil-associated conditions wit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of eosinophil-associated conditions wit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2098667